TABLE OF CONTENTS
1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 OVERVIEW OF NORTH AMERICA SURFACE DISINFECTANTS MARKET 22
1.4 LIMITATIONS 24
1.5 MARKETS COVERED 24
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 COMPOSITION LIFE LINE CURVE 33
2.7 MULTIVARIATE MODELING 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET END USER COVERAGE GRID 37
2.11 DBMR MARKET CHALLENGE MATRIX 38
2.12 DBMR VENDOR SHARE ANALYSIS 39
2.13 IMPORT-EXPORT DATA 39
2.14 SECONDARY SOURCES 41
2.15 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHT 46
4.1 U.S SURFACE DISINFECTANT ANALYSIS 47
4.2 EPIDEMIOLOGY 48
4.2.1 INCIDENCE 48
4.2.2 TREATMENT RATE 48
4.2.3 MORTALITY RATE 49
4.2.4 PATIENT TREATMENT SUCCESS RATE 49
4.3 INDUSTRIAL INSIGHTS: 50
4.3.1 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 50
4.3.2 KEY PRICING STRATEGIES 50
4.3.2.1 PRICES OF RAW MATERIALS: 50
4.3.2.2 FLUCTUATION IN DEMAND AND SUPPLY 50
4.3.2.3 LEVELS OF DISINFECTION 51
4.3.3 QUALITY: 51
4.3.4 KEY CONSUMER ENROLLMENT STRATEGIES 51
4.3.5 INTERVIEWS WITH DISINFECTION PRODUCT MANUFACTURERS 51
4.3.6 INTERVIEWS WITH INFECTIOUS DISEASE SCIENTISTS 52
4.4 PESTLE ANALYSIS 53
4.4.1 POLITICAL FACTORS 53
4.4.2 ECONOMIC FACTORS 53
4.4.3 SOCIAL FACTORS 53
4.4.4 TECHNOLOGICAL FACTORS 54
4.4.5 LEGAL FACTORS 54
4.4.6 ENVIRONMENTAL FACTORS 54
4.5 PORTERS FIVE FORCES: 55
4.5.1 THREAT OF NEW ENTRANTS: 55
4.5.2 THREAT OF SUBSTITUTES: 55
4.5.3 CUSTOMER BARGAINING POWER: 56
4.5.4 SUPPLIER BARGAINING POWER: 56
4.5.5 INTERNAL COMPETITION (RIVALRY): 56
5 NORTH AMERICA SURFACE DISINFECTANT MARKET: REGULATORY FRAMEWORK 58
6 MARKET OVERVIEW 61
6.1 DRIVERS 63
6.1.1 INCREASING DEMAND FROM HEALTHCARE FACILITIES 63
6.1.2 RISE IN OCCURRENCES OF CHRONIC DISORDERS 63
6.1.3 RISING PRODUCT DEMAND POST THE OUTBREAK OF COVID-19 64
6.1.4 SHIFTING CONSUMERS' PREFERENCE TOWARD USE OF BIO-BASED AND NATURE-FRIENDLY DISINFECTANTS 65
6.2 RESTRAINTS 65
6.2.1 LACK OF UNDERSTANDING REGARDING THE USE OF STANDARD DISINFECTION PRACTICES BY END-USERS 65
6.2.2 AVAILABILITY OF ALTERNATIVE PRODUCTS AND TECHNOLOGIES IN THE MARKET 66
6.3 OPPORTUNITIES 67
6.3.1 RISING AWARENESS AMONG A LARGE PERCENTAGE OF POPULATION 67
6.3.2 INCREASING FOCUS ON RESEARCH AND DEVELOPMENT (R&D) INITIATIVES 67
6.4 CHALLENGES 68
6.4.1 ENVIRONMENTAL & HEALTH HAZARDS ASSOCIATED WITH THE USE OF DISINFECTANTS 68
6.4.2 HIGHER PRICE OF CHEMICAL-BASED SURFACE DISINFECTANTS COMPARED TO BIO-BASED DISINFECTANTS 69

7 NORTH AMERICA SURFACE DISINFECTANTS MARKET, COMPOSITION 70
7.1 OVERVIEW 71
7.2 ALCOHOLS 72
7.3 CHLORINE 72
7.4 QUATENARY AMMONIUM 73
7.5 ALDEHYDES 74
7.6 PEROXIDES 74
7.7 BIO DISINFECTANTS 75
8 NORTH AMERICA SURFACE DISINFECTANTS MARKET, BY TYPE 76
8.1 OVERVIEW 77
8.2 LIQUID 78
8.3 WIPES 79
8.4 SPRAYS 79
9 NORTH AMERICA SURFACE DISINFECTANTS MARKET, BY APPLICATION 81
9.1 OVERVIEW 82
9.2 SURFACE DISINFECTION 83
9.3 INSTRUMENT DISINFECTION 83
9.4 OTHER APPLICATIONS 84
10 NORTH AMERICA SURFACE DISINFECTANTS MARKET, END USER 85
10.1 OVERVIEW 86
10.2 HOSPITALS 87
10.3 DIAGNOSTIC AND RESEARCH LABORATORIES 87
10.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 88
10.5 FOOD & BEVERAGES 89
10.6 RESIDENTIAL 90
11 NORTH AMERICA SURFACE DISINFECTANTS MARKET, BY REGION 91
11.1 NORTH AMERICA 92
11.1.1 U.S. 98
11.1.2 CANADA 100
11.1.3 MEXICO 102
12 NORTH AMERICA SURFACE DISINFECTANT MARKET: COMPANY LANDSCAPE 104
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 104
12.1.1 COLLABORATION 105
12.1.2 PRODUCT LAUNCHES 105
12.1.3 PARTNERSHIP 105
12.1.4 EVENT 106
13 SWOT ANALYSIS 107
14 COMPANY PROFILES 108
14.1 THE CLOROX COMPANY 108
14.1.1 COMPANY SNAPSHOT 108
14.1.2 REVENUE ANALYSIS 108
14.1.3 COMPANY SHARE ANALYSIS 109
14.1.4 PRODUCT PORTFOLIO 109
14.1.5 RECENT UPDATE 110
14.2 PAUL HARTMANN AG 111
14.2.1 COMPANY SNAPSHOT 111
14.2.2 REVENUE ANALYSIS 111
14.2.3 COMPANY SHARE ANALYSIS 112
14.2.4 PRODUCT PORTFOLIO 112
14.2.5 RECENT UPDATES 113
14.3 PROCTER & GAMBLE 114
14.3.1 COMPANY SNAPSHOT 114
14.3.2 REVENUE ANALYSIS 114
14.3.3 COMPANY SHARE ANALYSIS 115
14.3.4 PRODUCT PORTFOLIO 115
14.3.5 RECENT UPDATE 116
14.4 DIVERSEY HOLDINGS LTD. 117
14.4.1 COMPANY SNAPSHOT 117
14.4.2 REVENUE ANALYSIS 118
14.4.3 COMPANY SHARE ANALYSIS 118
14.4.4 PRODUCT PORTFOLIO 119
14.4.5 RECENT UPDATE 120
14.5 RECKITT BENCKISER GROUP PLC. 121
14.5.1 COMPANY SNAPSHOT 121
14.5.2 REVENUE ANALYSIS 121
14.5.3 COMPANY SHARE ANALYSIS 122
14.5.4 PRODUCT PORTFOLIO 122
14.5.5 RECENT UPDATES 123
14.6 BETCO 124
14.6.1 COMPANY SNAPSHOT 124
14.6.2 PRODUCT PORTFOLIO 124
14.6.3 RECENT UPDATE 125

14.7 BRULIN 126
14.7.1 COMPANY SNAPSHOT 126
14.7.2 PRODUCT PORTFOLIO 126
14.7.3 RECENT UPDATE 126
14.8 CARROLLCLEAN 127
14.8.1 COMPANY SNAPSHOT 127
14.8.2 PRODUCT PORTFOLIO 127
14.8.3 RECENT UPDATES 127
14.9 CETYLITE, INC 128
14.9.1 COMPANY SNAPSHOT 128
14.9.2 PRODUCT PORTFOLIO 128
14.9.3 RECENT UPDATE 129
14.10 CONTEC, INC. 130
14.10.1 COMPANY SNAPSHOT 130
14.10.2 PRODUCT PORTFOLIO 130
14.10.3 RECENT UPDATES 131
14.11 ECOLAB 132
14.11.1 COMPANY SNAPSHOT 132
14.11.2 REVENUE ANALYSIS 132
14.11.3 PRODUCT PORTFOLIO 133
14.11.4 RECENT UPDATES 134
14.12 GESCO HEALTHCARE PVT. LTD. 135
14.12.1 COMPANY SNAPSHOT 135
14.12.2 PRODUCT PORTFOLIO 135
14.12.3 RECENT UPDATE 136
14.13 GOJO INDUSTRIES, INC. 137
14.13.1 COMPANY SNAPSHOT 137
14.13.2 PRODUCT PORTFOLIO 137
14.13.3 RECENT UPDATE 138
14.14 KINNOS INC. 139
14.14.1 COMPANY SNAPSHOT 139
14.14.2 PRODUCT PORTFOLIO 139
14.14.3 RECENT UPDATES 140
14.15 MEDALKAN 141
14.15.1 COMPANY SNAPSHOT 141
14.15.2 PRODUCT PORTFOLIO 141
14.15.3 RECENT UPDATES 142

14.16 MEDIVATORS, INC 143
14.16.1 COMPANY SNAPSHOT 143
14.16.2 PRODUCT PORTFOLIO 143
14.16.3 RECENT UPDATE 143
14.17 MEDLINE INSUSTRIES, LP. 144
14.17.1 COMPANY SNAPSHOT 144
14.17.2 PRODUCT PORTFOLIO 144
14.17.3 RECENT UPDATES 145
14.18 METREX RESEARCH, LLC 146
14.18.1 COMPANY SNAPSHOT 146
14.18.2 PRODUCT PORTFOLIO 146
14.18.3 RECENT UPDATES 147
14.19 OXY PHARM 148
14.19.1 COMPANY SNAPSHOT 148
14.19.2 PRODUCT PORTFOLIO 148
14.19.3 RECENT UPDATES 148
14.20 PAL INTERNATIONAL 149
14.20.1 COMPANY SNAPSHOT 149
14.20.2 PRODUCT PORTFOLIO 149
14.20.3 RECENT UPDATES 150
14.21 PDI, INC. 151
14.21.1 COMPANY SNAPSHOT 151
14.21.2 PRODUCT PORTFOLIO 151
14.21.3 RECENT UPDATES 152
14.22 PHARMAX LIMITED 153
14.22.1 COMPANY SNAPSHOT 153
14.22.2 PRODUCT PORTFOLIO 153
14.22.3 RECENT UPDATES 153
14.23 PURPOSEBUILT BRANDS 154
14.23.1 COMPANY SNAPSHOT 154
14.23.2 RECENT UPDATE 155
14.24 RUHOF 156
14.24.1 COMPANY SNAPSHOT 156
14.24.2 PRODUCT PORTFOLIO 156
14.24.3 RECENT UPDATE 157
14.25 S.C. JOHNSON & SON INC. 158
14.25.1 COMPANY SNAPSHOT 158
14.25.2 PRODUCT PORTFOLIO 158
14.25.3 RECENT UPDATES 159

14.26 SPARTAN CHEMICAL COMPANY, INC. 160
14.26.1 COMPANY SNAPSHOT 160
14.26.2 PRODUCT PORTFOLIO 160
14.26.3 RECENT UPDATES 161
14.27 STERIS 162
14.27.1 COMPANY SNAPSHOT 162
14.27.2 REVENUE ANALYSIS 162
14.27.3 PRODUCT PORTFOLIO 163
14.27.4 RECENT UPDATES 164
14.28 WHITELEY 165
14.28.1 COMPANY SNAPSHOT 165
14.28.2 PRODUCT PORTFOLIO 165
14.28.3 RECENT UPDATES 166
14.29 ZEP INC. 167
14.29.1 COMPANY SNAPSHOT 167
14.29.2 PRODUCT PORTFOLIO 167
14.29.3 RECENT UPDATES 168
14.30 3M 169
14.30.1 COMPANY SNAPSHOT 169
14.30.2 REVENUE ANALYSIS 169
14.30.3 PRODUCT PORTFOLIO 170
14.30.4 RECENT UPDATES 171
15 QUESTIONNAIRE 172
16 RELATED REPORTS 175

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.